Conferences

BIOSPAIN 2010 will feature an extensive program of breakout sessions addressing the most relevant topics in the current biotech scenario.

 

Confirmed breakout sessions will include:

 

 

SEPTEMBER 29, 2010

 

09.30a.m. - 11.30a.m.

PUBLIC PROCUREMENT OF INNOVATIVE TECHNOLOGIES IN BIOTECHNOLOGY

Moderator:

Mr. Federico Baeza, (Deputy Director, COTEC).

Speakers:

Ms. María Josefa Montejo, (Expert, COTEC).

Dr. Josep Castell (Managing Director, IUCT).

Ms. María Luisa Castaño Marín, (Subdirectorate General for Public-Private Partnership Strategies, Ministry of Science and Innovation).

Dr. Joan Ballesteros, (President and Scientific Manager, Vivia Biotech).

Dr. José Javier Castrodeza, (Managing Director for Public Health and Research, Development and Innovation, Junta de Castilla y León).

Dr. Felipe Prósper, (PETHEMA & University Clinic of Navarra).

Ms. Neus Colet, (Technical Secretariat, Administrative Contracting Consultation Committee, Government of Catalonia).

 

15.00p.m. - 15.30p.m.

CANADA: BUILDING BIOTECH BRIDGES

Speaker:

Dr. Sean Thompson, (Former Vice President Corporate Development & General Manager, IntelliMab™).

 

15.30p.m. - 17.30p.m.

BIOINFORMATIC SOLUTIONS FOR GENOMICS: FROM SEQUENCE TO BIOTECHNOLOGY AND BIOMEDICINE

Moderator:

Dr. Paulino Gómez-Puertas (Severo Ochoa Molecular Biology Centre, Madrid)

Speakers:

Dr. Eduardo Pareja, (CEO, Era7 Information Technologies). "Next generation sequencing real world applications"

Dr. Jan-Jaap Wesselink, (R&D & Genomic Services Director , Biomol Informatics). "Genomic Sequence Analysis: Is GATTACA still science fiction?"

Mr. José Pablo Román, (Bioinformatics Manager, Genómica S.A.U.). "Custom software development in bioinformatics and its application to microarray-based technologies".

 

15.30p.m. - 17.30p.m.

BIOTECH'S NEXT BIG THING? BOOMING TECHNOLOGIES & BIOTECHNOLOGICAL APPLICATIONS

Moderator:

Dr. Fernando Terrón, (Partner, Biolty).

Speakers*:

Dr. Alan Paau, (Executive Director & Vice Provost for Technology Transfer & Economic Development, Cornell University).

Dr. Aya Jakobovits, (Executive Vice President  & Chief Scientific Officer, Agensys, Inc.).

Dr. Pablo Ortíz, (CEO, Digna Biotech).

*other speakers to be confirmed soon.

 

18.00p.m. - 19.30p.m.

PRESENT AND FUTURE SITUATION OF BIOFUELS: WHAT CAN BIOTECHNOLOGY DO FOR ITS IMPLEMENTATION AND USE?

Moderator:

Dr. Nora Alonso, (Managing Director, Iden Biotechnology).

Speakers:

Dr. Pablo Gutierrez & Mr. Ricardo Arjona, (Abengoa Bioenergy).

Mr. Xavier Garatea, (Spain Area Manager, Envitec Biogas).

Ms. Inés Echeverría Goñi, (Biomass Department Director, CENER).

Dr. José Luis Adrio, (Bioindustrial Division Director, Neuron Bph).

Dr. Dennis Byron, (Vice President for Crop Development, Pioneer Hi-Bred).

Mr. Carlos Alberto Fernández López, (Head of Biofuels Department, IDAE).

 

18.00p.m. - 19.30p.m.

ORPHAN DRUGS: JUST A RARITY OR THE FOREFRONT OF PERSONALIZED MEDICINE?

Moderator:

Dr. Fernando Royo, (VP Internacional de Relaciones Gubernamentales de GENZYME España).

Speakers:

Ms. Ana Belén Irigaray, (Regularoty Affairs Manager, Pharmamar).

Dr. José Luis Bravo, (VP Global Medical, Research & Development, Cellerix). VP Global Médico y Regulatorio

Dr. Francisco Palau (Scientific Director, CIBERER).

Dr. Olga Genilloud, (Scientific Director, Fundación Medina).

Mr. Stuart Medina, (Executive Director, Proretina Therapeutics S.L.).

 

 

SEPTEMBER 30, 2010

 

09.00a.m. - 10.30a.m.

TECHNICAL & ORGANIZATIONAL ALTERNATIVES TO INCREASE EFFICIENCY IN PROTEIN MANUFACTURE

Moderator:

Mr. Dámaso Molero, (General Director, 3P Biopharmaceuticals)

Speakers:

Dr. Fernando de Mora, (Director, Salupharma Biosimilars S.A.). "Biosimilars".

Dr. José Ángel M. Escribano, (Co-founder & Scientific Advisor, Algenex). "Insects as biofactories: an industrial revolution in scale and productivity".

Dr. Cristian Smerdou (Researcher at the Gene Therapy and Hepatology Department of the Center for Applied Medical Research- CIMA). “Therapeutic protein expression using a novel non-cytopathic Semliki Forest virus vector”.

Dr. David Blanco, (Project Manager, 3P Biopharmaceuticals). “CMOs aimed to an efficient and multiproject management”.

 

09.00a.m. - 10.30a.m.

ALTERNATIVE EQUITY MARKET FOR GROWTH COMPANIES

Moderator:

Mr. Josep Echarri, (Managing Director and CEO of Inveready Seed Capital SCR, S.A. and Member of the Board of Directors of Oryzon Genomics).

Speakers:

Mr. Jesús González Nieto-Márquez, (Vice-President and Managing Director of the Spanish Alternative Stock Market).

Mrs. Barbara Lunghi , (London Stock Exchange Group / Alternative Market for Growth Companies).

Mr. Ignasi Costas, (Partner of RCD S.L., Rousaud Costas y Durán).

Mr. Francisco González Carrera, (Nominated Adviser on the Spanish Alternative Stock Market, Ernst & Young).

Mr. Miguel Ángel Bonachera, (CEO, AB-Biotics).

Mr. Javier Velasco, (Managing Director, Neuron BPh).

 

15.30p.m. - 17.00p.m.

OPPORTUNITIES TO PARTICIPATE IN THE VII FRAMEWORK PROGRAMME

Moderator:

Ms. Isabel García Carneros, (Executive Director, Spanish Bioindustry Association).

Speakers:

Ms. Marta Gómez Quintanilla, (Expert & National Contact Point – HEALTH & BIO/KBBE under FP7, CDTI-Centre for the Development of Industrial Technology, the Ministry of Science and Innovation). “Open calls in Health and KBBE”.

Dr. Pablo Ortíz, (CEO, Digna Biotech). “How SMES solve the difficulties to participate in the VII Framework Programme”.

Dr. Miguel Mulet, (CEO, Coretherapix). “Succesful Project presentation in the Health Cooperation Programme”.

Dr. Beatriz Mendibil, (Project Manager, Zabala Innovation Consulting). “The Methodology that Zabala follow to help companies to obtain the financial return of the European Commission in the frame of the agreement with ASEBIO”.

 

15.30p.m. - 17.30p.m.

ALZHEIMER AND OTHER NEURODEGENERATIVE DISEASES: What is the Spanish industry doing to develop new drugs?

Moderator:

Dr. Miguel Lainez Andrés, (President, Fundación Grupo ERESA).

Speakers:

Dr. Javier Burgos, (Biopharma Unit Director, Neuron BPh).

Dr. Tamara Maes, (Scientific Director, Oryzon Genomics).

Dr. Teodoro del Ser, (Clinical Development Director, Noscira).

Dr. Pedro Pesine, (Laboratory Director, Araclon Biotech).

 

17.30p.m. - 19.30p.m.

FUNDING OPPORTUNITIES WITHIN THE BIOTECH SECTOR

Moderator:

Mr. Ignacio Pérez Salazar, (Director, Canaliza Banca de Inversión - Caja de Navarra).

Speakers:

Mr. Gil Bar-Nahum, (Senior Vice President, Jefferies Healthcare Investment Banking).

Dr. Piyush Unalkat, (Principal, European Investment Fund).

Dr. Héctor Ara, (President, Suanfarma Biotech).

Mr. Ignasi Fonts, (Co-CEO, Inveready Seed Capital SCR, S.A.).

Mr. Richard P. Kivel, (Chairman & CEO, Rhapsody Biologics and Chairman, MIT Enterprise Forum Global).

Mr. Manuel López-Figueroa, (Vice-President, Bay City Capital).

 

18.00p.m. - 19.30p.m.

INNOVATIVE BIOTECHNOLOGY APPLICATIONS TO PROMOTE COMPETITIVENESS IN THE FOOD SECTOR

Moderator:

Mr. Fidel Rodríguez, (CEO, Bioaurum).

Speakers:

Ms. Mercedes Larrain, (Research Manager, Tecnolat).

Dr. Daniel Ramón, (Executive Director, Biopolis). "New omics technologies in functional food".

Dr. Ángel Cebolla, (Executive Director, Biomedal). "Analytical techniques of self-defense against food poisoning".

Dr. Jesús Jiménez, (Executive Director, Ingredientis Biotech). "Discovery & development of bioactive compounds for functional foods".

Dr. Nuria Mª Arribas Vera, (General Secretary, Spanish Technology Platform Food for Life-Spain). "Succesful cases in the food area".

 

 

1 DE OCTUBRE, 2010

 

09.00a.m. - 10.30a.m.

DRUGS: FROM CHEMISTRY TO BIOTECHNOLOGY

Moderator:

Dr. Jesús M. Hernández (Deputy Director, Center for Applied Medical Investigation - CIMA).

Speakers:

Dr. José Luis Motellón, (Scientific Director, Amgen Spain). “Biotechnology: An innovative approach to fulfill unmet medical needs”.

Mr. Carlos Martín Piera, (Research and Development Manager, Madrid Biotechnology Plant, Merck SL). “Continuous improvements in industrial Biotechnology”.

Ms. Sonia Barrón ,(Business Development & Licensing Manager of Palau Pharma). "Biotechnology and its impact on Palau's Drug Discovery Process".

Mr. Angel Ursúa, (Technical Director, Idifarma). "Drug products development and regulatory technical requirements: differences according to the nature of the active ingredients”.

 

09.00a.m. - 10.30a.m.

INTERNATIONAL TECHNOLOGY COMMERCIALIZATION: THE CHALLENGES OF US-EUROPEAN PUBLIC-PRIVATE PARTNERSHIPS

Moderator:

Mr. Michael Rosen, (Vice President, New Business Development, Forest City Science+Technology Group).

Speakers*:

Dr. José María Fernández-Sousa, (President, Zeltia Group).

Dr. Arturo Azcorra, (Managing Director, CDTI-Centre for the Development of Industrial Technology, Ministry of Science and Innovation).

Dr. Wesley D. Blakeslee, (Executive Director, Technology Transfer Johns Hopkins University, USA).

Dr. Jenny Hunter Cervera, (Executive Vice President, Discovery & Analytical Sciences and Corporate Development for the Research Triangle of North Carolina, USA).

Ms. Milagros Candela Castillo, (Head Counselor for Science and Innovation, Permanent Representation of Spain to the European Union).

Ms. Elise Lyons, (Director - European Office, Department of Business & Economic Development, US State of Maryland).

 

11.00a.m. - 12.30p.m.

NEW PROSPECTS FOR BIOTECHNOLOGY IN AGRICULTURE

Moderator:

Dr. Emilio Rodríguez Cerezo, (Agriculture and Life Sciences in the Economy Unit, JRC-IPTS).

Speakers:

Dr. Gema Pérez Farinós, (Environmental Biology Department, CIB-CSIC). "Environmental safety of GMO varieties; previous evaluation and monitoring".

Ms. Esther Esteban Rodrigo, (Ministry of Environment, Spain). "Impact on the new EU regulations on GMO crop varieties".

Dr. Jaime Costa, (Agriculture & Environment Work Group Coordinator, ASEBIO). "Regulation of GMO crops: effects on innovation and value chain".

 

11.00a.m. - 12.30p.m.

HOW TO FINANCE YOUR INTERNATIONL PARTNERSHIP - JOINT TECHNOLOGY COOPERATION PROGRAMS

Moderator:

Dr. Jorge Arenas, (Director, BioSerentia Group).

Speakers*:

Mr. Emilio Iglesias Cadarso, (Area Manager, Eureka & Eurostars programs, CDTI).

Dr. Bill Dobson, (Director, National Research Council, Ontario Region, Canada).

Dr. Aharon Rosenstein, (Technological Cooperation Expert, MATIMOP – Israel Industry Centre for R&D).

*other speakers to be confirmed soon.